We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Repligen Seeks IND for Drug to Treat Friedreich’s Ataxia
Repligen Seeks IND for Drug to Treat Friedreich’s Ataxia
May 21, 2010
Repligen has submitted an IND for a drug to treat a rare genetic defect that causes the body to produce too little of a protein central to healthy nerve function.